Salsabila Hapsari, Raira
Unknown Affiliation

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Comparative Dissolution Formulation and Test Simvastatin Ko-Crystal Tablets With Isonicotinamide As Coformer Sopyan, Iyan; Novianti, Ina; Abdassah Bratadiredja, Marline; Salsabila Hapsari, Raira; Setiawati, Ervina
Indonesian Journal of Pharmaceutics Vol 6, Issue 2, May - August 2024
Publisher : Universitas Padjadjaran (Unpad)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24198/idjp.v5i3.55250

Abstract

Simvastatin is a statin drug used to lower plasma cholesterol in all types of hyperlipidemia. Simvastatin is included in BCS class II with poor solubility.  One of the efforts made to increase the solubility of simvastatin is the formation of co-crystals. Co-crystal is a modified type of crystal habit, which consists of two or more molecules in the same crystal lattice. The purpose of this study was to obtain the best excipient combination formula on the simvastatin co-crystalline tablet with isonicotinamide as a coformer and its comparable dissolution test results. The excipient combination optimization was carried out using a two-level factorial method. The optimized Avicel pH 102 and Primogel produced four combination designs on ready-made formulas, namely F1 Avicel pH 102: Primogel (79:2), F2 Avicel pH 102: Primogel (79:8), F3 Avicel pH 102: Primogel (85: 2) and F4 Avicel pH 102: Primogel (85: 8). The evaluation includes evaluating the mass of the print and the quality of the tablets. The excipient combination design solution in the best formula is Avicel pH 102 and Primogel with a ratio (79: 8). The method used in a comparable dissolution test is to compare the values of F1 (difference factor) and F2 (similarity factor) using BootStrap software. The F2 values observed were 50.3 at pH 1.2, 56.09 at pH 4.5, and 59.23 at pH 6.8, which indicates that the simvastatin co-crystalline tablet has similarities with the innovator tablet. The excipient combination design solution in the best formula is Avicel pH 102 and Primogel with a ratio (79: 8). The method used in a comparable dissolution test is to compare the values of F1 (difference factor) and F2 (equation factor) using BootStrap software. The F2 values observed were 50.3 at pH 1.2, 56.09 at pH 4.5, and 59.23 at pH 6.8, which indicates that the simvastatin co-crystalline tablet has similarities with the innovator tablet.Keywords: Simvastatin, co-crystal, two-stage factorial, comparable dissolution                     test.
Increasing Solubility of Simvastatin Via Salting Form Using Isonicotinamide As Co-Formers Sopyan, Iyan; Puspa, Inge; Salsabila Hapsari, Raira
Indonesian Journal of Pharmaceutics Vol 6, Issue 2, May - August 2024
Publisher : Universitas Padjadjaran (Unpad)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24198/idjp.v6i2.60538

Abstract

Simvastatin is a drugs used to lower plasma cholesterol. Simvastatin is a class II BCS drug that has low solubility and high permeability. One of the efforts made to increase the solubility of simvastatin is the formation of multicomponent crystals (co-crystals and salts). The purpose of this study was to determine the solubility and dissolution profile of multicomponent crystal simvastatin with the best co-former candidate from the in silico test. Simvastatin-co-former multicomponent crystal were prepared using solvent drop grinding method with a mol ratio of 1:1 ; 1:2 and 2:1. Based on the result of value of binding affinity and ability to form hydrogen bonds, isonicotinamide was chosen as the co-former in this research. Evaluation of multicomponent crystals was carried out by solubility and dissolution tests. The evaluation results showed an increase in the solubility and dissolution of the simvastatin-isocotinamide multicomponent crystal with the highest increase occurring in the simvastatin-isocotinamide multicomponent crystal with a mol ratio of 1:2. Multicomponent crystal characterization was carried out to determine physicochemical characteristics. The results of characterization using infrared spectrophotometry showed a spectrum shift. The results of the Differential Scanning Calorimetry (DSC) analysis show a decrease in the melting point. The results of Powder X-ray diffraction analysis showed that there were differences in the shape of the crystals indicated by the formation of new peaks on the diffractogram. So, it can be concluded that simvastatin-isocotinamide multicomponent crystals are able to increase solubility and dissolution compared to pure simvastatin.